Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA).

Fox KM, Henderson JR, Bertrand ME, Ferrari R, Remme WJ, Simoons ML.

Eur Heart J. 1998 Sep;19 Suppl J:J52-5.

PMID:
9796841
2.

Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.

Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML; EUROPA investigators..

Int J Cardiol. 2007 Sep 14;121(1):57-61.

PMID:
17270296
3.

EUROPA: has anything new been learned with angiotensin-converting enzyme inhibitors?

Sica DA.

J Clin Hypertens (Greenwich). 2004 Feb;6(2):91-5. Review.

4.

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.

Daly CA, Fox KM, Remme WJ, Bertrand ME, Ferrari R, Simoons ML; EUROPA Investigators..

Eur Heart J. 2005 Jul;26(14):1369-78.

PMID:
15860521
5.
6.

The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.

Brugts JJ, Boersma E, Chonchol M, Deckers JW, Bertrand M, Remme WJ, Ferrari R, Fox K, Simoons ML; EUROPA Investigators..

J Am Coll Cardiol. 2007 Nov 27;50(22):2148-55.

7.

EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.

Simoons ML, Vos J, de Feyter PJ, Bots ML, Remme WJ, Grobbee DE, Kluft C, de Maat MP, Fox KM, Deckers JW.

Eur Heart J. 1998 Sep;19 Suppl J:J56-60. Review.

PMID:
9796842
8.

[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].

Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.

Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Review. Italian.

PMID:
16485513
9.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators..

Lancet. 2003 Sep 6;362(9386):782-8.

PMID:
13678872
11.

Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.

Ferrari R, Bertrand ME, Remme WJ, Simoons ML, Deckers JW, Fox KM.

Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1037-46. Review.

PMID:
18035919
12.
13.

Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?

Boos CJ.

Med Sci Monit. 2004 Dec;10(12):SR23-8.

PMID:
15567997
14.

[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].

Rapezzi C, Ciliberti P, Graziosi M, Riva L.

Ital Heart J. 2005 Nov;6 Suppl 7:40S-47S. Review. Italian.

PMID:
16485516
15.

Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.

Ferrari R, Fox K.

Drugs. 2009;69(3):265-77. doi: 10.2165/00003495-200969030-00003. Review.

PMID:
19275271
16.

Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.

Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A; Japanese Acute Myocardial Infarction Prospective study group..

Am Heart J. 2004 Aug;148(2):e8.

PMID:
15309011
18.

Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease.

Fox KM, Bertrand ME, Remme WJ, Ferrari R, Simoons ML, Deckers JW; EUROPA Investigators..

Am Heart J. 2007 Apr;153(4):629-35.

PMID:
17383303
19.
20.

Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial.

Bertrand ME, Fox KM, Remme WJ, Ferrari R, Simoons ML.

Arch Cardiovasc Dis. 2009 Feb;102(2):89-96. doi: 10.1016/j.acvd.2008.10.012.

Supplemental Content

Support Center